Stem cell eye drops show promise for Hard-to-Treat corneal damage
NCT ID NCT05204329
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety of eye drops made from stem cell secretions in 9 adults with chronic corneal surface disease that did not improve with standard treatments. The drops were given in increasing doses to find the safest amount. Researchers checked for side effects and measured changes in the cornea's surface and vision over 28 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Birth control pills could reshape your cornea, study suggests
- Popular diabetes drugs may ease dry eye, study suggests
- Just one cigarette changes your eyes in minutes, study finds
- Brain and eye scans reveal how pain heals after cornea surgery
- Stem cell shot may heal diabetic foot sores
- New camera-like device could help doctors see tissue health without cutting